Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of ($0.07), $0.03 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $36.4 million versus the consensus estimate of $32.02 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.